LifeSplice Pharma is an early-stage biotech company that develops extraordinarily specific, potent, and long lasting RNA-based drugs called 'Splice Modulating Oligomers' (SMOs) to treat severe neurological and non-neurological diseases with critical unmet medical needs. The LifeSplice platform technology relies upon innovative and cost-effective in-silico drug design, validated by its founding scientists, that allows for extremely rapid discovery of new SMO product candidates.
Looking for a particular LifeSplice Pharma employee's phone or email?
LifeSplice Pharma Questions
The LifeSplice Pharma annual revenue was $811000 in 2026.
Melanie Tallent is the Chief Scientific Officer of LifeSplice Pharma.
1 people are employed at LifeSplice Pharma.
LifeSplice Pharma is based in Malvern, Pennsylvania.
The NAICS codes for LifeSplice Pharma are [32541, 325, 3254, 32].
The SIC codes for LifeSplice Pharma are [28, 283].
Top LifeSplice Pharma Employees
-
Melanie Tallent
Chief Scientific Officer at LifeSplice Pharma
Malvern, PA, US25+
Related Companies
